Transactions

$94 Million
Joint Bookrunner
Initial Public Offering
April 2021

$128 Million
Joint Bookrunner
Initial Public Offering
April 2021

$50 Million
Sole Agent
At-The-Market (ATM) Facility
April 2021

$35 Million
Sole Agent
At-The-Market (ATM) Facility
April 2021

$75 Million
Sole Bookrunner
Follow-On
April 2021

$75 Million
Co-Agent
At-The-Market (ATM) Facility
April 2021

$50 Million
Sole Agent
At-The-Market (ATM) Facility
March 2021

$105 Million
Joint Bookrunner
Follow-On
March 2021

UNDISCLOSED
Exclusive Financial Advisor
Merger with Tempest Therapeutics
Pending

UNDISCLOSED
Exclusive Financial Advisor
Practice Partnership with LucidHealth
March 2021

$75 Million
Sole Agent
At-The-Market (ATM) Facility
March 2021

$406 Million
Joint Bookrunner
Initial Public Offering
March 2021
- « Previous Page
- Page 1
- Page 2
- Page 3
- ...
- Page 63
- Next Page »